نتایج جستجو برای: dipeptidyl peptidase 4

تعداد نتایج: 1310834  

Journal: :Meditsinskiy sovet = Medical Council 2020

2013
Lin Lin Wei Sun Ben Throesch Faith Kung Jameice T Decoster Cory J Berner Richard E. Cheney Bernardo Rudy Dax A Hoffman

Dipeptidyl-peptidase 6 is an auxiliary subunit of Kv4-mediated A-type K(+) channels that, in addition to enhancing channel surface expression, potently accelerates their kinetics. The dipeptidyl-peptidase 6 gene has been associated with a number of human central nervous system disorders including autism spectrum disorders and schizophrenia. Here we employ knockdown and genetic deletion of dipep...

2013
Henrike Sell Matthias Blüher Nora Klöting Raphaela Schlich Miriam Willems Florian Ruppe Wolfram Trudo Knoefel Arne Dietrich Barbara A. Fielding Peter Arner Keith N. Frayn Jürgen Eckel

OBJECTIVE To study expression of the recently identified adipokine dipeptidyl peptidase-4 (DPP4) in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) of patients with various BMIs and insulin sensitivities, as well as to assess circulating DPP4 in relation to obesity and insulin sensitivity. RESEARCH DESIGN AND METHODS DPP4 expression was measured in SAT and VAT from 196 sub...

2016
Jennifer Hayes Rosie Anderson Jeffrey W Stephens

Type 2 diabetes mellitus is a progressive disease associated with significant morbidity and mortality. There is good evidence showing that intensive glycemic control reduces the development and progression of complications. In order to achieve glycemic targets, patients often require a combination of oral therapy and/or insulin in addition to lifestyle modification. Unfortunately, many of the t...

2017
John B. Buse M. Angelyn Bethel Jennifer B. Green Susanna R. Stevens Yuliya Lokhnygina Pablo Aschner Carlos Raffo Grado Tsvetalina Tankova Julio Wainstein Robert Josse John M. Lachin Samuel S. Engel Keyur Patel Eric D. Peterson Rury R. Holman

OBJECTIVE We evaluated the incidence of acute pancreatitis and pancreatic cancer in patients with type 2 diabetes and cardiovascular disease who were treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i). RESEARCH DESIGN AND METHODS In the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) study, a cardiovascular safety study of sitagliptin, all suspected cases ...

Journal: :Hospital pharmacy 2014
Patricia A Howard

Cardiovascular (CV) disease is a major cause of morbidity and mortality in patients with diabetes. Whereas the link between glycemic control and reducing microvascular disease is firmly established, the evidence for macrovascular risk reduction remains unclear. Despite a host of available drugs for lowering serum glucose, none to date have been shown to substantially reduce CV risk and some hav...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید